Core Viewpoint - Fort Wayne Medical Oncology and Hematology (FWMOH) has joined the American Oncology Network (AON), enhancing its patient-focused services and maintaining high-quality cancer care in northeastern Indiana [1][4]. Company Overview - FWMOH has been providing cancer care since 1977 and operates nine locations in northeastern Indiana, staffed by 16 Board-certified medical oncologists and two Board-certified gynecologic oncologists [2][6]. - The organization treats over 40 types of cancer and various blood disorders, emphasizing compassionate, patient-centered care [6][7]. Partnership Details - The partnership with AON allows FWMOH to pursue growth initiatives and innovations, enhancing care for more patients in the region [2][3]. - AON, founded in 2018, represents over 290 providers across 21 states and focuses on value-based care, improving patient outcomes while reducing costs [10]. Service Offerings - FWMOH provides comprehensive cancer care, including laboratory services, PET/CT imaging, oral and IV infusion treatment options, clinical trials, and survivorship programs [3][6]. - The facilities are designed for patient comfort, featuring private exam rooms and on-site infusion suites [3]. Leadership Statements - Dr. Praveen Kollipara, president of FWMOH, expressed excitement about the partnership, highlighting recent expansions and the addition of leading gynecologic oncologists [2]. - AON's leadership emphasized the shared commitment to high-quality, patient-centered care and the expertise FWMOH brings to the network [4][5].

Group 1: ASH Annual Meeting - The ASH Annual Meeting is a premier event for hematology research, with over 5,000 scientific abstracts submitted annually, showcasing significant contributions to the field [1] - Selected abstracts undergo rigorous peer review, highlighting vital advancements in cancer care [4] Group 2: American Oncology Network (AON) - AON is an alliance of physicians and healthcare leaders focused on the long-term success of community oncology, founded in 2018, representing over 250 providers across 21 states [4] - AON promotes innovative healthcare solutions through a physician-led model, emphasizing value-based care to improve patient outcomes while reducing costs [4] - The organization is committed to health equity, addressing disparities in cancer care to ensure all patients have access to necessary care [4] Group 3: Hematology Oncology of Indiana - Hematology Oncology of Indiana is a community-based practice providing treatment for various cancers and blood disorders, focusing on compassionate patient-centered care [5] - Physicians from Hematology Oncology of Indiana presented impactful research findings at the 66th ASH Annual Meeting, emphasizing their commitment to advancing cancer care [6][9] - The practice co-authored a study on CAR T-Cell Therapy integration in community oncology centers, published in the November supplemental issue of Blood [7]

Core Viewpoint - American Oncology Network (AON) has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC), highlighting its commitment to high-quality patient care and compliance with national standards [1][5]. Company Overview - AON is one of the fastest-growing oncology networks in the United States, founded in 2018, and represents over 250 providers across 21 states [1][5]. - The organization focuses on innovative healthcare solutions through a physician-led model, promoting value-based care that enhances patient outcomes while reducing costs [5]. - AON aims to address disparities in cancer care and ensure equitable access to healthcare for all patients [5]. Specialty Pharmacy Operations - AON's specialty pharmacy collaborates with physicians and pharmacists to deliver oral cancer medications directly to patients' homes, ensuring quick dispensing and shipping [4]. - The pharmacy team also assists patients with insurance claims and connects them to financial assistance programs [4]. Accreditation Significance - ACHC accreditation signifies an organization's dedication to meeting rigorous standards for performance and patient care [2][3]. - ACHC has been a recognized symbol of quality since 1986 and is ISO 9001:2015 certified, with authority from the Centers for Medicare & Medicaid Services (CMS) [3][6].

FORT MYERS, FL, Dec. 19, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (OTCQX:AONC), one of the fastest-growing oncology networks in the United States, proudly announces that its specialty pharmacy has achieved reaccreditation from the Accreditation Commission for Health Care (ACHC). Accreditation is a process through which health care organizations demonstrate compliance with national standards. ACHC accreditation reflects an organization's dedication to meeting standards that facilitate a highe ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04177 American Oncology Network, Inc. (Exact name of registrant as specified in its charter) Delaware 85-3984427 (State or other jurisdiction of incorp ...

CAPE CORAL, FL.,, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Community oncology practice Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX: AONC), is pleased to announce patients now have another additional choice for medical oncology services in Lee County due to its continued expansion in Florida with the opening of its new location in Cape Coral where Board-certified medical oncologists Magali Van den Bergh, MD, Venkata Parsa, MD, and Shivtaj Mann, DO are now accepting ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-04177 American Oncology Network, Inc. (Exact name of registrant as specified in its charter) Delaware 85-3984427 (State or other jurisdiction of incorporati ...

FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network ("AON" or the "Company") (OTCQX:AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day. To access the call through a conference line, dial 1-877-704- ...

Company Overview - American Oncology Network (AON) is an alliance of physicians and healthcare leaders focused on the long-term success of community oncology and other specialties, founded in 2018 [4] - AON's network includes over 240 providers across 21 states, emphasizing innovative healthcare solutions through a physician-led model [4] - The organization aims to improve patient outcomes while reducing costs and expanding access to quality care, promoting health equity in cancer care [4] Research and Development - The research project co-authored by Dr. M. Sarfraz Nawaz focuses on improving care for patients with febrile neutropenia, a serious complication in cancer patients [1][2] - The study aims to create a standard precaution protocol for hospitalized neutropenic patients and will collect data over the next six months to inform this protocol [2] - The project was presented at the 21st International Ultmann Chicago Lymphoma Symposium, highlighting its significance in advancing knowledge in lymphoma treatment [1][2][3] Professional Recognition - Dr. Nawaz's participation in the symposium was recognized as a significant contribution to advancing medical knowledge, reflecting AON's culture of research and scholarly exchange [3] - The rigorous selection process for the symposium validated the project's value to the field of oncology [2][3]

Core Points - American Oncology Network, Inc. (AON) has qualified to trade on the OTCQX Best Market, transitioning from NASDAQ to enhance trading transparency and convenience for investors [1][2] - The OTCQX Best Market is designed for established companies that meet high financial standards and corporate governance practices, providing a better trading experience for investors [1][3] - AON's Class A Common Stock and Warrants began trading under the symbols "AONC" and "AONCW" respectively, with current financial disclosures available on OTC Markets [2] Company Overview - AON is a rapidly growing network of community-based oncology practices, founded in 2018, representing over 240 providers across 21 states [4] - The company focuses on innovative healthcare solutions through a physician-led model, aiming to improve patient outcomes while reducing costs and expanding access to quality cancer care [4] - AON is committed to promoting health equity by addressing disparities in cancer care and ensuring all patients have access to necessary treatments [4]